Detalles de la búsqueda
1.
Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children Ë5 years in Cameroon, 2011-2018.
PLoS One
; 16(4): e0250010, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33857235
2.
Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era.
J Microbiol Immunol Infect
; 53(6): 1035-1038, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32475800
3.
Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.
Clin Vaccine Immunol
; 18(3): 367-72, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21191076
4.
Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
Clin Vaccine Immunol
; 17(1): 154-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19906895
5.
Antibody persistence in UK pre-school children following primary series with an acellular pertussis-containing pentavalent vaccine given concomitantly with meningococcal group C conjugate vaccine, and response to a booster dose of an acellular pertussis-containing quadrivalent vaccine.
Vaccine
; 27(37): 5096-102, 2009 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19573637
6.
Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Vaccine
; 24(16): 3248-57, 2006 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-16480794
7.
A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age.
Vaccine
; 24(18): 3964-70, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16517034
8.
Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.
Infect Immun
; 71(10): 5549-55, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14500473
9.
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
Infect Immun
; 70(9): 4946-54, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12183540
Resultados
1 -
9
de 9
1
Próxima >
>>